Conversely, the sensitivity of H1975 cells (an NSCLC cell line with EGFR L858R/T790M mutation) to erlotinib was enhanced by inhibiting YAP through the use of small interfering RNA (siRNA) or verteporfin. Here, EGFR is linked to non-small cell lung carcinoma.